NCT01819779View on ClinicalTrials.gov

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy Male Subjects
Interventions
DRUG

Exforge tab. 10/160mg

DRUG

Lodivixx tab. 5/160mg

Trial Locations (1)

430-720

Metro Hospital, Anyang

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT01819779 - Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60) | Biotech Hunter | Biotech Hunter